8/8/2019 AAMNArticle
2/4
sub-types, changes in the Heamagluttinin (H) and Neura-miniadase
(N) makes large portions o the population im-munologically nave on
a regular basis (1). The problem withType A is that it undergoes
both antigenic drit and antigenicshit making it more dangerous and
unpredictable (1). The
WorldHealthOrganizationdeclaredtheH1N1SwineFluapandemicinJuneof2009(3).
TheannualaverageU.S.winterepidemicsaffect5%to20%ofthepopulation.
The CDC (1) reports the ollowing pandemic death histories:
Yr Flu Deaths
1889 RussianFluH2H2 1,000,000
1918 SpanishFluH1N1 40,000,000
1957 Asian Flu H2N2 1,500,000
1968 HongKongH3N2 750,000
Health Care Practitioners Are At the Highest Risk
Doctors, nurses and other health care providers are at
thehighestriskofbecominginfectedwithInuenza.Because
doctors are exposed to the virus most requently, it is
signicanttorecognizethesurvivabilityoftheInuenzavirusinopen
environments.
MammalianInuenzaAsurvives1hourinmucous,whilAvianInuenzasurvives100daysinwater,200days@63F,1dayinfecesandindenitelywhenfrozen.Inuenzaiseasily
transmitted rom human to human as indicated in theollowing
table.
Infuenza Transmission Rates (CDC, 2009)
Bodyuidsandhandtohandcontact 70%Airborne 29%
Animal 1%
The Following Are Proven To Destroy the Infuenza Virus
(CDC, 2009)
Bleach 70%ethanol Aldehydes Oxidizing agents
Quaternaryamoniumcompounds Inactivatedbyheat(133)for60minutes pH
less than 2 (very acidic) SilverSol(liquidandgel)
Doctors have the obligation to protect themselves
andtheirpatientsfromthepotentiallypandemicInuenzavirues. This
protection could come rom many dierent sourceincluding Vaccination,
Hygiene, Anti viral drugs, Antibioticdrugs, Nutritional
supplements, Air lters, Water
puriers,Masks,TopicalgelsandSilverSol.
Past epidemics provide important insights into what
mighhappeninthepotentialspreadofthecurrentSwineFlu(4-13). The most
persistent viruses survive and the most
diversseemtogoextinctwithinafewyears(14,15).Thisismolikely the
result o strong host-mediated selection pressure,resulting in
continual evolution at key antigenic sites, a pro-
cesstermedantigenicdrift(15,16).Thisantigenicevolu-tion is
observed with major changes in antigenicity
occurrinperiodicallyinpatternsofapproximately3yearsbetweenepisodes(17).
According to reports rom the Army Medical
records,(fromthe1918SpanishFlu,H1N1epidemic)24%ofthepeoplediedfromthevirusand76%diedformasecond-ary
bacterial inection that produced pneumonia in thelungs. There is a
high probability that the swine fu willhave similar death rates,
and i this is the case, then preventing and treating the secondary
bacterial inection will be as
SUMMER/FALL 2009 ANTI-AGING MEDICAL NEWS 4
8/8/2019 AAMNArticle
3/4
important i not more important. Theconclusion is that the
infuenza viruswill need to be treated by multiple orcombination
therapies crossing viraland bacterial lines.
Recommendations or Infuenza
prevention and treatment (1)
Hygiene: The CDC recommendswashing the hands ater any
exposurebecause most infuenza is transerredby hand contact. Masks
and gloves can
help but the mask must t tightly withno leaks to be eective. A
surgical maskhelps protect the persons around thewearer, so i you
have a ever, cough orsneeze, wear a surgical mask to protectthe
patients.
Anti viral drugs: These drugs havethe ability to destroy viruses
but cannotbe taken or an extended period o time.They produce side
eects that mimicthe fu making it dicult to diagnose
theseverityofthedisease.Iftakenforprevention, Tamifu produces
resistance.18%oftheinuenzavirusisresistanttoTamiualready(1).Itissuspectedthat
the health care proessionals whowere taking it or our months as
apreventive agent were the persons thatdeveloped resistance. This
indicatesthat we cannot use the antiviral
drugsforlongperiodsoftime.Inaddition,some drugs cannot be used in
childrenunder13yearsofage(Tamiu).Re -
lenza cannot be used in children
underoneorinadultsover65.Theantiviralsmust be given within 48 hours
o theonset o illness or the virus will run itscourse. Combine this
with the act that76%ofH1N1subjectsintheSpanishfu 1918, died rom a
bacterial inec-tion that produced pneumonia andyou have an
incomplete solution to theinfuenza problem. Because Tamifu
hasdevelopedresistanceRelenzamaybeabetter choice as long as you
monitor thebronchospasms.
Antibiotic Drugs:Antibiotic drugsprovide no solution against the
virus butcan be very benecial or pneumoniathat develops later. A
broad spectrumantibiotic should be used because thereare numerous
bacteria that can
producepneumonia.AccordingtoaPennStatepublication, silver sol can
be given withthe antibiotics and produce up to a ten-old increase
in antibiotic activity (18).
Nutritional Supplements: There are
hundreds o supplements that can beo signicant benet or the
immunesystem and even some that claim tohave antiviral activity.
The best provenchoices or nutritional supplementscome in the orm o
immune stimu-lants and wellness products. Theseinclude: immunity
Vit C, B complex,olic acid, vit D (prevention) ginseng,Echinacea,
garlic, probiotics, expecto-rants and silver sol.
Air Filters: CDC recommends one inevery room. HEPA air lters use
silver
In order to control an epidemic, all types o treatment should be
employed including prescription drugs,
vitamins, mineral, herbs, proper hygiene, air fltration, water
fltration and the proper use o diet and
nutritional supplements, especially the newly patented, FDA
approved Silver Sol technology.
42 ANTI-AGING MEDICAL NEWS SUMMER/FALL 2009
8/8/2019 AAMNArticle
4/4
to inactivate viruses and can
eectivelykill99%ofallbacteria,andvirusesinminutes.
Water Purifers: Proper hygiene anda water purier are recommended
bythe CDC because the infuenza
viruscansurvive100hoursinwater.Getonethat has a silver lter that
can actuallydestroy the virus. Carbon, ltration,
reverse osmosis does not destroy orremove the virus.
Topical Disinectants: Topicaldisinectants are recommended by
theCDC or use between each patient
andcankillgermsfor4-6hours.Patientsand health care proessionals
shoulduse these 4 times a day or as
needed.Silversolgeldemonstrateseffectivenessagainst some o the
worst pathogensincluding:MRSA,VRE,Strep,andthe
other bacteria that cause pneumonia.
Silver Sol: Prescription drugs andvaccines treat and help
prevent viralinection and disease but are not capableo totally
controlling a dangerous newor novel virus (18). Nutritional
supple-ments such as Vitamins, Minerals,
Echi-nacea,Ginseng,Probioticsandmanyothers have the ability to help
boostimmune unction and improve naturaldeenses which results in
some deenseagainst disease causing viruses and the
associated secondary
inectionsSilverSolprovidesprovenprevention
and treatment against viral and bacterialinections, while there
is nothing elsewith such broad spectrum benets
(19).Inaddition,SilverSolcanbesafelytaken every day or prevention
whereit has been shown to provide protec-tion against the very
dangerous Bird
fuH5N1.Thecombinationofantibiot-icswithSilverSolhasbeenshowntoenhance
antibiotic unction by as much
astenfoldduetothefactthatSilverSolkillstheresidualpathogensthattheantibioticscannot(19).Resultsofthecombination
o 19 dierent prescrip-tion antibiotics and silver sol demon-strate
sae additive and/or
synergisticbenetsacross7differentpathogenicstrains(Staphyloccocus,MRSA,Ecoli,Pseudomonasarugenosa,SalmonellaandStreptococcus).Theresultsofthiscombination
therapy result in signicantpathogenic destruction while helping
toreduce bacterial resistance (19). This
canbeattributedtothefactthatSilverSoldoesnotproduceresistance,nordoes
it destroy the benetcial intestinalprobiotic bacteria (18).
Discussion:
H1N1 is a serious threat to our healthand way o lie. The best
way to treatinfuenza is to prevent it. Preventionproduces a problem
in that drugs haveserious side eects and cannot be usedby the
entire population and should notbe used or long periods o time.
Theother problem is that approximatelythree ourths o the people who
havedied rom H1N1 infuenza have suc-cumbed to a secondary bacterial
inec-tion in the lungs and no antiviral drugwill treat this
condition.
Inordertocontrolanepidemic,alltypes o treatment should be
employedincluding prescription drugs, vitamins,
mineral, herbs, proper hygiene, air ltra-tion, water ltration
and the proper useo diet and nutritional supplements,especially the
newly patented, FDA ap-provedSilverSoltechnology.SilverSoldestroys
bacteria, viruses, and mold so itdemonstrates broader spectrum o
activ-ity than any antibiotic or antiviral
drug.Itcanbetakendailyduethefactthatit passes through the body
unchanged,and can prevent viral inections, treatthem and work
synergistically with
antibiotics to produce as much as aten old increase in activity
against thebacteria that cause death in
infuenza.ItisevidentthatthenewlypatentedEPAcertiedandFDAapprovedSilverSoltechnologyprovidestremendoustreatment
options or prevention andcombinationtherapies.SilverSolgelcan help
stop viral spread on the mostcontagious areas like hands, nose,
mouthandskin.Itissufcientlydocumentedand proven to be considered to
be a rstlineofdefenseagainstInuenzaanda
signicant companion to antiviral andantibacterial drug regimens
topicallyand orally.u
REFERENCES
1. CDC. Update: swine-origin infuenza A (H1N1)
virus---UnitedStatesandothercountries.MMWR
2009;58:421.
2.NovelSwine-OriginInuenzaA(H1N1)Virus
InvestigationTeam.Emergenceofanovelswine-
origin infuenza A (H1N1) virus in humans. N Engl
JMed2009;361.
3.WorldHealthOrganization.Situationupdates---
inuenzaA (H1N1).Geneva,Switzerlan
World Health Organization; 2009.
4.RoweT,AbernathyRA,Hu-PrimmerJ,etal.De -
tection o antibody to avian infuenza A
(H5N1)virusinhumanserum byusingacombi
nationofserologicassays.JClinMicrobiol1999;
37:937--43.
5.LaverWG,WebsterRG.Selectionofantigenic
mutantsofinuenzaviruses.Isolationandpeptid
mapping o their hemagglutination proteins. Virol
gy. 1968;34:193202.
6.SleighMJ,BothGW,UnderwoodPA,BenderVJ.
Antigenic drit in the hemagglutinin o the Hong
Kong infuenza subtype: correlation o amino acid
changes with alterations in viral antigenicity. J Vir
1981;37:845853.
7.FitchWM,LeiterJMF,LiX,PaleseP.PositiveDar
winian evolution in human infuenza A viruses. Pr
Natl Acad Sci. 1991;88:42704272.
8.BushRM,FitchWM,BenderCA,CoxNJ.Positive
selectionontheH3hemagglutiningeneofhuman
infuenza virus A.Mol Biol Evol. 1999;16:1457
1465.
9.RvachevLA.Computermodelingexperiment
on large-scale epidemic. Dokl USSR Acad Sci.
1968;2:294296.
10.LonginiIM,FinePE,ThackerSB.Predictingthe
global spread o new inectious agents.Am J Epide
miol. 1986;123:383391.
11. Bonabeau E, Toubiana L, Flahault A. The ge-
ographical spread o infuenza. Proc Biol Sci.
1998;265:24212425.
12.GraisRF,EllisJH,GlassGE.Assessingtheimpact
o airline travel on the geographic spread o pande
mic infuenza. Eur J Epidemiol. 2003;19:1065107
13.ViboudC,BjrnstadON,SmithDL,SimonsenL,MillerMA,etal.Synchrony,waves,andspatial
hierarchies in the spread o infuenza. Science.
2006;312:447451.
14.BuonagurioDA,NakadaS,ParvinJD,KrystalM,
Palese P, Fitch WM. Evolution o human infuenza
virusesover50years:rapid,uniformrateofchang
inNSgene.Science. 1986;232:980982.
15.FitchWM,LeiterJMF,LiX,PaleseP.PositiveDa
winian evolution in human infuenza A viruses. Pr
Natl Acad Sci. 1991;88:42704272.
16.FitchWM,BushRM,BenderCA,CoxNJ.Long
termtrendsintheevolutionofH(3)HA1human
infuenza type A. Proc Natl Acad Sci. 1997;94:771
7128.
17.SmithDJ,LapedesAS,deJongJC,BestebroerTM
RimmelzwaanGF,OsterhausAD,FouchierRA.
Mapping the antigenic and genetic evolution o
infuenza virus. Science. 2004;305:371376.
18.ThompsonWW,ShayDC,WeintraubE,Bramme
L, Cox N, et al. Mortality associated with infuenz
andrespiratorysyncytialvirusintheUnitedState
JAMA. 2003;289:179186.
19.DeSouza.A.,Mehta,D,Bactericidalactivityof
CombinationsofSilver-WaterDispersionwith19
AntibioticsAgainstSevenMicrobialStrains.Cur-
rentScience,Vol91,No7,October2006.
SUMMER/FALL 2009 ANTI-AGING MEDICAL NEWS 4
